Docetaxel (Taxotere) and gemcitabine in combination therapy
- PMID: 10458206
Docetaxel (Taxotere) and gemcitabine in combination therapy
Abstract
In patients with advanced cancers, gemcitabine and docetaxel (Taxotere; Rhône-Poulenc Rorer, Antony, France) can be administered together at 80% to 100% of their single-agent doses on days 1 and 8 of an every-3-week cycle without undue toxicity. In phase 1/11 studies, this combination has demonstrated activity against a range of tumors, including non-small cell lung cancer, and may represent an alternative to cisplatin-based chemotherapy. In advanced cancer, benefits in quality of life are likely to result. The fact that the combination of gemcitabine and docetaxel is generally well tolerated also suggests that the regimen should be assessed in the adjuvant and neoadjuvant settings.
Similar articles
-
Docetaxel (Taxotere) and gemcitabine phase I and early phase II studies: results to date and an overview of ongoing studies.Semin Oncol. 1999 Jun;26(3 Suppl 10):8-11. Semin Oncol. 1999. PMID: 10437744 Review.
-
Docetaxel (Taxotere) in non-small cell lung cancer: ongoing studies in Heidelberg and future plans.Semin Oncol. 1999 Jun;26(3 Suppl 11):23-7. Semin Oncol. 1999. PMID: 10458207 Review.
-
Challenging the platinum combinations: docetaxel (Taxotere) combined with gemcitabine or vinorelbine in non-small cell lung cancer.Semin Oncol. 2001 Feb;28(1 Suppl 2):15-21. doi: 10.1016/s0093-7754(01)90299-4. Semin Oncol. 2001. PMID: 11284620 Review.
-
Docetaxel (Taxotere) and gemcitabine in the treatment of non-small cell lung cancer: preliminary results.Semin Oncol. 1997 Aug;24(4 Suppl 14):S14-22-S14-25. Semin Oncol. 1997. PMID: 9335520 Clinical Trial.
-
Docetaxel (Taxotere) as a single agent and in combination chemotherapy for the treatment of patients with advanced non-small cell lung cancer.Semin Oncol. 2000 Apr;27(2 Suppl 3):3-10. Semin Oncol. 2000. PMID: 10810932 Review.
Cited by
-
Gemcitabine and docetaxel for hepatocellular carcinoma: a phase II North Central Cancer Treatment Group clinical trial.Am J Clin Oncol. 2012 Oct;35(5):418-23. doi: 10.1097/COC.0b013e318219863b. Am J Clin Oncol. 2012. PMID: 21555932 Free PMC article. Clinical Trial.
-
Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer.Med Oncol. 2006;23(4):507-13. doi: 10.1385/MO:23:4:507. Med Oncol. 2006. PMID: 17303909 Clinical Trial.
-
Outpatient therapy with gemcitabine and docetaxel for gallbladder, biliary, and cholangio-carcinomas.Invest New Drugs. 2002 Aug;20(3):351-6. doi: 10.1023/a:1016209901417. Invest New Drugs. 2002. PMID: 12201499 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical